Developing robotic system for endovascular procedures - Sentante – a smart, sensory, teleoperated robot system which allows the procedure to be performed remotely, from a different room, thus protecting physicians from harmful X-rays and opening up tele-surgery possibilities. For more information, please visit our website: https://sentante.com/ Sentante is designed to be controlled in the same way as a manually performed endovascular procedure – by using the conventional endovascular instruments –guidewires and catheters. The proprietary patented technology is able to “sense” operators’ movements and provide close to natural haptic force feedback ensuring intuitive control of endovascular instruments – while operating remotely, physicians can still feel the catheter and guidewire resistance just as if they were standing near the patient.
| Website | http://www.sentante.com |
| Employees | 33 (33 on RocketReach) |
| Industry | Medical Equipment Manufacturing |
| Keywords | Medical Robotics, Surgical Robots, Robotic Surgery Systems, Precision Robotics, Smart Robotics, Remote Surgery, Robot Assisted Surgery, Remote Controlled Robots, Endovascular Devices, Minimally Invasive Surgery, Surgical Technology, Surgical Devices, Medical Technology, Healthcare Technology, Medical Devices, X Ray Protection |
| Competitors | Clearsense, LLC, Health Catalyst, Oracle Health Information, Epic, Optum, McKesson, IBM, Landin Ofshore, Tableau, Qlik +39 more (view full list) |
Looking for a particular Sentante employee's phone or email?
Edvardas Satkauskas is the CEO of Sentante.
33 people are employed at Sentante.